Gemcitabine

Common brands: Avgemsi, Cisplatin, Abraxane, Carboplatin, Kyxata

Top reporter: Avyxa Pharma, Llc

Platinum-based Drug [EPC]Microtubule Inhibitor [EPC]Corticosteroid [EPC]Alkylating Drug [EPC]Nucleoside Metabolic Inhibitor [EPC]
38,203
Total Reports
19,294
Serious Reports
7,242
Death Reports
30
Reported Reactions
Death Report Ratio: High (18.96%)

Patient Demographics

Male
15,972
Female
15,406

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Gemcitabine.

# Reaction Reports % of Total
1 DISEASE PROGRESSION 4,461
9.9%
2 THROMBOCYTOPENIA 2,909
6.5%
3 OFF LABEL USE 2,686
6.0%
4 NEUTROPENIA 2,599
5.8%
5 DRUG INEFFECTIVE 2,573
5.7%
6 ANAEMIA 2,380
5.3%
7 MALIGNANT NEOPLASM PROGRESSION 2,044
4.5%
8 NAUSEA 1,959
4.3%
9 PYREXIA 1,924
4.3%
10 FATIGUE 1,628
3.6%
11 DIARRHOEA 1,604
3.6%
12 VOMITING 1,568
3.5%
13 DEATH 1,468
3.3%
14 FEBRILE NEUTROPENIA 1,361
3.0%
15 DYSPNOEA 1,197
2.7%
16 ASTHENIA 1,116
2.5%
17 PNEUMONIA 1,053
2.3%
18 PANCYTOPENIA 967
2.1%
19 NEUROPATHY PERIPHERAL 956
2.1%
20 LEUKOPENIA 911
2.0%
21 ABDOMINAL PAIN 894
2.0%
22 PRODUCT USE IN UNAPPROVED INDICATION 874
1.9%
23 SEPSIS 868
1.9%
24 GENERAL PHYSICAL HEALTH DETERIORATION 814
1.8%
25 DECREASED APPETITE 791
1.8%
26 PLATELET COUNT DECREASED 732
1.6%
27 ACUTE KIDNEY INJURY 730
1.6%
28 RASH 698
1.5%
29 THROMBOTIC MICROANGIOPATHY 667
1.5%
30 PULMONARY EMBOLISM 659
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.